UCLA tests 'Retroactive' procedure to free kidney patients from lifelong meds
NCT ID NCT05525507
Summary
This early-stage study is testing a new approach for people who have already received a kidney transplant from a well-matched family donor. Researchers want to see if giving patients stem cells from the same donor, after a special preparation treatment, can teach their immune system to accept the transplanted kidney without needing lifelong anti-rejection drugs. The goal is to see if patients can safely stop these medications while keeping their kidney healthy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCLA
RECRUITINGLos Angeles, California, 90095, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.